While FAK is recognized as a central regulator of angiogenesis in breast cancer, its potential role in modulating the tumor microenvironment and promoting non-angiogenic vascularization, such as VM and VCO, remains largely unexplored. The gene discussed is PTK2; the disease is neoplasm.